Convexity Labs

NKE

Convexity Analyst · NKE
Sellhigh confidenceTactical · no named thesis
Generated Jun 21, 2026

Analyst Note: NIKE, Inc. (NKE)

Date: 2026-06-13 Sector: Consumer Discretionary

1. Structural Readiness

*Correction on State Classification based on Data:*

2. Thesis Layer

As of 2026-06-13, there is no named secular thesis attached to this setup. This is a TACTICAL, setup-led name. The investment case must be judged strictly on the quality of the technical structure (which is currently failed) and the immediate business fundamentals provided in the evidence. No macro or thematic thesis should be inferred to justify the setup.

3. Business Overview

NIKE, Inc. operates as the largest global seller of athletic footwear, apparel, equipment, and accessories. The company designs, develops, and markets products under the NIKE, Jordan, and Converse brands.

Business Model & Channels:

  • Distribution: Sales occur through two primary channels: NIKE Direct (owned retail stores and digital platforms) and Wholesale (independent distributors, licensees, and sales representatives).
  • Geography: In fiscal 2025, U.S. sales accounted for 43% of total revenue, while non-U.S. sales accounted for 57%.
  • Manufacturing: Production is concentrated in Vietnam (51%), Indonesia (28%), and China (17%).

Current Operational Status (as of Q3 FY2026 / March 2026):

  • Revenue Pressure: Management expects revenues to be down low single digits for the period, driven by declines in Greater China due to "intentionally reduced sell-in and marketplace management actions."
  • Win Now Actions: Management stated on March 31, 2026, that they expect to have "finished our Win Now actions" by the end of the calendar year (Dec 2026).
  • Product Performance: NIKE Running is up over 20% for the quarter, and the new NIKE MIND platform (focused on athlete mental performance) has sold out with over 2 million "Notify Me" sign-ups, prompting a doubling of production.
  • Wholesale: NIKE Brand wholesale revenues were $6.5 billion for Q3 FY2026, up from $6.2 billion in the prior year quarter.
  • Margins: Gross margin for Q3 FY2026 decreased 130 basis points to 40.2%, primarily due to higher tariffs in North America. Management expects gross margin expansion to begin in Q2 FY2027 as tariff impacts are mitigated and "Win Now" recovery takes hold. Tariffs are expected to remain a material headwind through Q1 FY2027.

4. Archetype and Conviction

Archetype: Margin Inflector / Deep Value Recovery (Attempted). The setup attempts to position NKE as a "Margin Inflector" where management actions ("Win Now") and tariff mitigation are expected to drive margin expansion starting Q2 FY2027.

Conviction Analysis:

  • Thesis Strength: Low. The setup is invalidated. The "Margin Inflector" narrative is currently being contradicted by the structural breakdown.
  • Evidence Quality: Moderate. Management has provided clear guidance on the "Win Now" timeline (ending Dec 2026) and tariff impacts (ending Q2 FY2027). Product innovation (MIND, Running) shows strength.
  • Setup Readiness: None. The setup is invalidated. The aggressive entry of $64.60 is now a resistance level, not an entry.
  • Rerating Potential: Dependent on the successful execution of the "Win Now" actions and the resolution of tariff headwinds in FY2027. However, the technical structure suggests the market has already priced in significant distress or a lack of confidence in the near-term turnaround.

ATR Context:

5. Invalidating Factors and Gaps

Strengthening Factors:

  • Successful completion of "Win Now" actions by Dec 2026.
  • Gross margin expansion beginning in Q2 FY2027 as planned.
  • Sustained growth in NIKE Running and MIND platform adoption.

Gaps in Evidence:

  • Missing Evidence: There is no specific data on the *current* inventory levels or sell-through rates for the "Win Now" period as of June 2026, only the *expectation* of completion by year-end.
  • Missing Evidence: No specific data on the *magnitude* of the tariff impact in Q2 FY2027 beyond the statement that it will be the "final quarter" of material headwind.
  • Missing Evidence: No specific guidance on the *timing* of the price recovery relative to the margin expansion.

PRIVATE ANALYST CALL

Judgment: Sell Confidence: high Key risks: Tariff impacts persisting longer than Q2 FY2027; Greater China weakness deepening beyond "low single digit" declines; Failure of "Win Now" actions to deliver margin expansion by year-end. Sizing hint: Position size should be zero; the setup is structurally broken. Expected path: Management expects to finish "Win Now" by Dec 2026 and see margin expansion in Q2 FY2027, but the market has priced in the interim distress, keeping price suppressed below structural support. Expected horizon: The invalidation is immediate; any recovery would require a new structural formation, likely taking multiple quarters to re-establish a base. Failure mode to watch: A close below the current price ($45.20) would signal further capitulation and a lack of support, confirming the structural breakdown is not a temporary dip.

Loading chart...
Exhibit 1: NKE daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for NKE.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for NKE.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: